Ms. Katherine Ann Valdivia, CCMA/CPT1 Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 710 Madison St # A, Watsonville, CA 95076 Phone: 831-251-8367 |
Dr. Nathan Cohen, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1430 Freedom Blvd, Watsonville, CA 95076 Phone: 831-763-8400 |
Jonathan B. Tallman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12 W Beach St, Watsonville, CA 95076 Phone: 831-763-8990 |
Dr. Jonathan Tepper, M.D., PH.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 240 Westgate Dr Ste 122, Watsonville, CA 95076 Phone: 831-728-3939 |
Robert H Edmund, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12 W Beach St, Watsonville, CA 95076 Phone: 831-454-4170 Fax: 831-454-4663 |
Narinder Raj Bhullar, M.D Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 64 Aspen Way, Ste. 101, Watsonville, CA 95076 Phone: 831-786-1660 Fax: 831-786-1663 |
Hassan S Dinakar, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1430 Freedom Blvd Ste F, Watsonville, CA 95076 Phone: 831-763-8200 |
Princy Arora, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 64 Aspen Way Ste 101, Watsonville, CA 95076 Phone: 831-786-1660 Fax: 831-786-1663 |
News Archive
Neurologix, Inc. (OTCBB:NRGX) announced today its financial results for the second quarter and six months ended June 30, 2009.
Dr. Frank Comstock, whose office is located at 6127 N. La Cholla, Suite 175, in Tucson, is now offering SottoPelleĀ®, a unique form of hormone replacement therapy, developed by internationally recognized Gino Tutera M.D., F.A.C.O.G., as a solution for patients who struggle with hormone imbalance and well-being.
Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground.
Delivering another innovation for interventional cardiology, Medtronic, Inc.,announced today the U.S. Food and Drug Administration (FDA) approval of the Integrity Coronary Stent System. The new platform for Medtronic's coronary stents, including the Integrity bare-metal stent, is based on an advance in biomedical engineering called continuous sinusoid technology that enables the exploration of other breakthrough device concepts such as a polymer free drug filled stent.
› Verified 4 days ago